The First Case of Basal Cell Carcinoma in the Scar Fifty Years After Leishmanization
-
Nelli Ignatievna Tumolskaya
,
Vladimir Petrovich Sergiev
,
Olga Petrovna Zelya
,
Valerij Dmitrievich Zavoikin
Abstract
Cutaneous leishmaniasis (CL) is a self-curing skin infection distributed in tropics and subtropics. Up to one million cases of CL appeared in endemic areas a year. Leishmanization (artificially controlled infections) was widely used to control cutaneous leishmaniasis in the past. Basal cell carcinoma (BCC) is the most common epithelial neoplasm of the skin. Cases of BCC developing in a leishmanial scar have been documented. We present the first case of confirmed basal cell carcinoma arising in 2020 in an 81-old physician working in Moscow (Russian Federation) in a leishmanial scar. It was 50 years after the primary lesion due to a successful leishmanization, widely used to control cutaneous leishmaniasis in the past.
1. World Health Organization. Leishmania-sis-key facts. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
2. Strelkova MV, Baranova AM, Kuhls K. History of the E.I. Martsinovsky Institute of Medical Parasitology and Tropical Med-icine: research on malaria and leishmania-sis. Hist Cienc Saude Manguinhos. 2020;27(4):1097-124.
3. Mohebali M, Nadim A, Khamesipour A. An overview of leishmanization experi-ence: A successful control measure and a tool to evaluate candidate vaccines. Acta Trop. 2019; 200:105173.
4. Sergiev V, Kondrashin A, Litvinov S, et al. Epidemiology and control of leishmaniasis in the Former USSR: A Review Article. Iran J Parasitol. 2018 Jul-Sep;13(3):342-350.
5. Amini H. Cutaneous lesions with very long duration as a complication of leishmaniza-tion. Iran J Public Health. 1991;20 (1-4):43-50.
6. Bloom BR, Lambert PH (Eds.). The Vac-cine Book, 2nd ed. San Diego (USA): Ac-ademic Press, 2016.
7. Morsy TA. Cutaneous leishmaniasis pre-disposing to human skin cancer: forty years local and regional studies. J Egypt Soc Parasitol. 2013;43(3):629-48.
8. Chisti M, Almasri R, Hamadah I. Is cuta-neous leishmaniasis a risk factor for basal cell carcinoma? Gulf J Oncol. 2016;1(21):64-6.
9. Unlü RE, Altun S, Ssensöz O. Leishmania scar: a risk factor for the development of basal cell carcinomas. J Craniofac Surg. 2007;18(3):708-10.
10. Kopterides P, Mourtzoukou EG, Skope-litis E, et al. Aspects of the association be-tween leishmaniasis and malignant disor-ders. Trans R Soc Trop Med Hyg. 2007;101(12):1181-9.
11. Nehal KS, Bichakjian CK. Update on keratinocyte carcinomas. N Engl J Med. 2018 26;379(4):363-374.
12. Asilian A, Momeni I, Khosravani P. Basal cell carcinoma superimposed on a cutane-ous leishmaniasis lesion in an immuno-compromised patient. J Res Med Sci. 2012;17(1):108-10.
13. Roewe RJ, Uhlman MA, Bockholt NA, et al. Basal Cell Carcinoma of the Penis: case report and review of the literature. Case Rep Urol. 2014;2014:173076.
2. Strelkova MV, Baranova AM, Kuhls K. History of the E.I. Martsinovsky Institute of Medical Parasitology and Tropical Med-icine: research on malaria and leishmania-sis. Hist Cienc Saude Manguinhos. 2020;27(4):1097-124.
3. Mohebali M, Nadim A, Khamesipour A. An overview of leishmanization experi-ence: A successful control measure and a tool to evaluate candidate vaccines. Acta Trop. 2019; 200:105173.
4. Sergiev V, Kondrashin A, Litvinov S, et al. Epidemiology and control of leishmaniasis in the Former USSR: A Review Article. Iran J Parasitol. 2018 Jul-Sep;13(3):342-350.
5. Amini H. Cutaneous lesions with very long duration as a complication of leishmaniza-tion. Iran J Public Health. 1991;20 (1-4):43-50.
6. Bloom BR, Lambert PH (Eds.). The Vac-cine Book, 2nd ed. San Diego (USA): Ac-ademic Press, 2016.
7. Morsy TA. Cutaneous leishmaniasis pre-disposing to human skin cancer: forty years local and regional studies. J Egypt Soc Parasitol. 2013;43(3):629-48.
8. Chisti M, Almasri R, Hamadah I. Is cuta-neous leishmaniasis a risk factor for basal cell carcinoma? Gulf J Oncol. 2016;1(21):64-6.
9. Unlü RE, Altun S, Ssensöz O. Leishmania scar: a risk factor for the development of basal cell carcinomas. J Craniofac Surg. 2007;18(3):708-10.
10. Kopterides P, Mourtzoukou EG, Skope-litis E, et al. Aspects of the association be-tween leishmaniasis and malignant disor-ders. Trans R Soc Trop Med Hyg. 2007;101(12):1181-9.
11. Nehal KS, Bichakjian CK. Update on keratinocyte carcinomas. N Engl J Med. 2018 26;379(4):363-374.
12. Asilian A, Momeni I, Khosravani P. Basal cell carcinoma superimposed on a cutane-ous leishmaniasis lesion in an immuno-compromised patient. J Res Med Sci. 2012;17(1):108-10.
13. Roewe RJ, Uhlman MA, Bockholt NA, et al. Basal Cell Carcinoma of the Penis: case report and review of the literature. Case Rep Urol. 2014;2014:173076.
| Files | ||
| Issue | Vol 17 No 1 (2022) | |
| Section | Case Report(s) | |
| DOI | https://doi.org/10.18502/ijpa.v17i1.9031 | |
| Keywords | ||
| Basal cell carcinoma Cutaneous leishmaniasis Leishmania Leishmanization | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Tumolskaya N, Sergiev V, Zelya O, Zavoikin V. The First Case of Basal Cell Carcinoma in the Scar Fifty Years After Leishmanization. Iran J Parasitol. 2022;17(1):101-104.
